Literature DB >> 22210137

Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or colonization.

C N T Dekker1, A Bouma, A J J M Daemen, L A M G van Leengoed, F H Jonker, J A Wagenaar, J A Stegeman.   

Abstract

Streptococcus suis (S. suis) is an important porcine pathogen worldwide, and antibiotics are often applied to treat or prevent clinical signs. Vaccination could be an alternative measure to reduce the abundant use of antimicrobials. The aim of this study was to determine the effect of vaccination with homologues whole bacterin vaccine containing S. suis serotype 9 strain 7997 on transmission of this serotype among pigs and on mucosal colonization. Caesarean derived, colostrum deprived pigs (N=50) were housed pair wise. Thirteen pairs were vaccinated intramuscularly with 2-3×10(9) colony forming units (CFU) inactivated S. suis serotype 9 per dose and α-tocopherolactetaat as adjuvant at 3 and 5 weeks of age; twelve pairs served as non-vaccinated controls. At 7 weeks of age, one pig of each pair was intranasally inoculated with 1-2×10(9)CFU of the homologues strain, whereas the other pig of each pair was contact-exposed. Tonsil brushings and saliva swabs were collected for 4 weeks, and tested for the presence of S. suis by bacteriological culture. No differences in number of S. suis in the tonsils or saliva samples or in clinical signs were observed between vaccinated and control pigs. In all pairs, transmission between inoculated and contact exposed pigs occurred, and no difference was observed in rate at which this occurred. The estimated transmission rate parameter β between vaccinated pigs was β(v)=5.27/day, and for non-vaccinated pigs β(nv)=2.77/day (P=0.18). It was concluded that vaccination against S. suis serotype 9 did not reduce transmission, nor colonization and that there were no indications that protection against clinical signs was induced.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22210137     DOI: 10.1016/j.vaccine.2011.12.035

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Salmonella enterica serovar Choleraesuis vector delivering a dual-antigen expression cassette provides mouse cross-protection against Streptococcus suis serotypes 2, 7, 9, and 1/2.

Authors:  Yu-An Li; Yanni Sun; Yang Fu; Yuqin Zhang; Quan Li; Shifeng Wang; Huoying Shi
Journal:  Vet Res       Date:  2022-06-22       Impact factor: 3.829

2.  Effect of Simultaneous Exposure of Pigs to Streptococcus suis Serotypes 2 and 9 on Their Colonization and Transmission, and on Mortality.

Authors:  Niels Dekker; Annemarie Bouma; Ineke Daemen; Hans Vernooij; Leo van Leengoed; Jaap A Wagenaar; Arjan Stegeman
Journal:  Pathogens       Date:  2017-09-27

3.  Update on Streptococcus suis Research and Prevention in the Era of Antimicrobial Restriction: 4th International Workshop on S. suis.

Authors:  Mariela Segura; Virginia Aragon; Susan L Brockmeier; Connie Gebhart; Astrid de Greeff; Anusak Kerdsin; Mark A O'Dea; Masatoshi Okura; Mariette Saléry; Constance Schultsz; Peter Valentin-Weigand; Lucy A Weinert; Jerry M Wells; Marcelo Gottschalk
Journal:  Pathogens       Date:  2020-05-14

4.  Molecular typing of Streptococcus suis strains isolated from diseased and healthy pigs between 1996-2016.

Authors:  T Louise Prüfer; Judith Rohde; Jutta Verspohl; Manfred Rohde; Astrid de Greeff; Jörg Willenborg; Peter Valentin-Weigand
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

5.  Antigen I/II Participates in the Interactions of Streptococcus suis Serotype 9 With Phagocytes and the Development of Systemic Disease.

Authors:  Jean-Philippe Auger; Anaïs-Christelle Boa; Mariela Segura; Marcelo Gottschalk
Journal:  Front Cell Infect Microbiol       Date:  2019-04-24       Impact factor: 5.293

6.  Vaccination with the immunoglobulin M-degrading enzyme of Streptococcus suis, Ide Ssuis, leads to protection against a highly virulent serotype 9 strain.

Authors:  Karoline Rieckmann; Anna Seydel; Kristin Klose; Gottfried Alber; Christoph G Baums; Nicole Schütze
Journal:  Vaccine X       Date:  2019-10-10

7.  Effect of spatial separation of pigs on spread of Streptococcus suis serotype 9.

Authors:  Niels Dekker; Annemarie Bouma; Ineke Daemen; Don Klinkenberg; Leo van Leengoed; Jaap A Wagenaar; Arjan Stegeman
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

8.  Association between transmission rate and disease severity for Actinobacillus pleuropneumoniae infection in pigs.

Authors:  Tijs J Tobias; Annemarie Bouma; Angeline J J M Daemen; Jaap A Wagenaar; Arjan Stegeman; Don Klinkenberg
Journal:  Vet Res       Date:  2013-01-11       Impact factor: 3.683

9.  Simultaneous Quantification and Differentiation of Streptococcus suis Serotypes 2 and 9 by Quantitative Real-Time PCR, Evaluated in Tonsillar and Nasal Samples of Pigs.

Authors:  Niels Dekker; Ineke Daemen; Koen Verstappen; Astrid de Greeff; Hilde Smith; Birgitta Duim
Journal:  Pathogens       Date:  2016-06-30

Review 10.  A critical review speculating on the protective efficacies of autogenous Streptococcus suis bacterins as used in Europe.

Authors:  Karoline Rieckmann; Sophia-Mareike Pendzialek; Thomas Vahlenkamp; Christoph G Baums
Journal:  Porcine Health Manag       Date:  2020-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.